查看購物車
  • Simplified Chinese
  • English
  • Japanese
封面
市場調查報告書
商品編碼
1612234

人工軟骨植入市場：按類型、最終用戶分類 - 2025-2030 年全球預測

Artificial Cartilage Implant Market by Type (Lower Extremity Joints, Upper Extremity Joints, Vertebral Joints), End-User (Ambulatory Surgery Centers, Clinics, Hospitals) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年，人工軟骨植入市場價值為1.1822億美元，預計2024年將達到1.3579億美元，複合年成長率為15.37%，預計到2030年將達到3.2169億美元。

人工軟骨植入市場包括用於替代或支撐受損軟骨的合成軟骨植入物，目的是恢復關節功能並減輕患有骨關節炎和外傷等疾病的患者的疼痛，涉及材料開發和商業化。這些植入對於改善生活品質至關重要，特別是對於更容易出現關節退化的老年人和運動員。應用主要針對膝關節、髖關節和踝關節的修復，對肩關節和肘關節等特殊區域的興趣日益濃厚。最終使用者包括整形外科診所、醫院、門診手術中心等。推動市場成長要素包括生物材料的進步、關節疾病盛行率的增加以及微創手術技術的創新。此外，不斷成長的醫療保健支出和對關節保護選擇的認知進一步提振了市場。潛在的機會在於開發耐用且生物相容的產品，服務於不斷發展的運動醫學領域，以及增加在醫療需求未被滿足的新興經濟體中的存在。然而，高成本、監管障礙和有限的報銷方案等挑戰可能會限制市場成長。此外，植入排斥的風險以及複製天然軟骨的複雜成分所涉及的技術困難可能會抑制快速進展。為了實現業務成長，我們應該專注於奈米技術創新，以提高植入的機械性能和組織完整性。對再生醫學的進一步研究，例如將幹細胞療法與人工植入結合，顯示出一條充滿希望​​的前進道路。該市場競爭激烈，主要參與者在研發方面投入巨資，並透過針對患者的設計和使用壽命等功能使自己脫穎而出。生物技術公司和研究機構之間的合作可以加強產品平臺並擴大市場範圍。為了利用當前趨勢，公司應專注於病患教育，與醫療保健提供者建立強大的夥伴關係，並確保其產品符合不斷變化的臨床需求和監管環境。

主要市場統計
基準年[2023] 11822萬美元
預測年份 [2024] 1.3579億美元
預測年份 [2030] 3.2169億美元
複合年成長率（%） 15.37%

市場動態：快速發展的人工植入市場的關鍵市場洞察

供需的動態交互作用正在改變人工軟骨植入市場。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 膝骨關節炎和腕骨盛行率增加
    • 人們對人工軟骨植入的認知不斷增強
    • 醫療支出的增加和醫療設施的進步
  • 市場限制因素
    • 人工軟骨和關節關節重建手術的高成本
  • 市場機會
    • 植入材料和手術技術的技術進步
    • 開發用於製造人工軟骨植入的智慧技術和3D列印技術
  • 市場挑戰
    • 人工軟骨植入相關的併發症因素

波特五力：駕馭人工軟骨植入市場的策略工具

波特的五力框架是了解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解人工軟骨植入市場的外部影響

外部宏觀環境因素在塑造人工軟骨植入市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助公司預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解人工軟骨植入市場的競爭狀況

對人工植入市場的詳細市場佔有率分析可以對供應商的績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 定位矩陣人工軟骨植入市場供應商的績效評估

FPNV 定位矩陣是評估人工軟骨植入市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析和建議，以規劃人工軟骨植入市場的成功之路

對於旨在加強其在全球市場的影響力的公司來說，對人工植入市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機，並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：對當前市場環境的詳細審查、主要企業的廣泛資料、對其在市場中的影響力和整體影響力的評估。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，以幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 膝關節和腕掌骨骨關節炎的盛行率增加
      • 人們對人工軟骨植入的認知不斷增強
      • 不斷上漲的醫療費用和先進的醫療設施
    • 抑制因素
      • 人工軟骨和置換手術的高成本
    • 機會
      • 植入材料和手術技術的技術進步
      • 開發用於生產人工軟骨植入的智慧和3D列印技術
    • 任務
      • 與人工軟骨植入相關的併發症
  • 市場區隔分析
    • 類型：由於骨關節炎高發生，下肢關節的需求增加人工軟骨植入
    • 最終用戶：大型患者照護機構對醫院人工軟骨植入的需求不斷增加
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章人工軟骨植入市場：依類型

  • 下肢關節
  • 上肢關節
  • 脊椎骨關節

第7章人工軟骨植入市場：依最終用戶分類

  • 門診手術中心
  • 診所
  • 醫院

第8章北美和南美人工植入市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區人工植入市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章 歐洲、中東、非洲人工軟骨植入市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
    • 瑞士大學資助 1,300 萬美元開始膝關節假體試驗
    • Sparta 加強 Olumi植入的專利保護
    • CartiHeal 宣佈在美國推出第一個 Agili-C商業性植入
  • 戰略分析和建議

公司名單

  • Anika Therapeutics, Inc.
  • BioPoly, LLC
  • CartiHeal, Inc. by Smith & Nephew PLC
  • CytoSeek Limited
  • Medtronic PLC
  • Narang Medical Limited
  • NUsurface
  • Orthox Ltd.
  • Sartorius CellGenix GmbH
  • Sparta Biomedical Inc.
  • Stryker Corporation
  • Uteshiya Medicare
  • Zimmer Biomet Holdings, Inc.
Product Code: MRR-351BAD503B27

The Artificial Cartilage Implant Market was valued at USD 118.22 million in 2023, expected to reach USD 135.79 million in 2024, and is projected to grow at a CAGR of 15.37%, to USD 321.69 million by 2030.

The artificial cartilage implant market involves the development and commercialization of synthetic materials used to replace or support damaged cartilage, aiming to restore joint functionality and alleviate pain in patients suffering from conditions like osteoarthritis or traumatic injuries. These implants are crucial for enhancing life quality, especially for aging populations and athletes prone to joint degradation. Applications primarily target knee, hip, and ankle repairs, with growing interest in specialized areas like shoulder and elbow joints. End-users include orthopedic clinics, hospitals, and ambulatory surgical centers. Key growth factors driving the market include advancements in biomaterials, increasing prevalence of joint disorders, and technological innovations in minimally invasive surgical techniques. Additionally, rising healthcare expenditure and awareness around joint preservation alternatives further propel the market. Potential opportunities lie in developing enhanced products with greater durability and bio-compatibility, catering to the expanding sports medicine field, and increasing presence in emerging economies with unmet medical needs. However, challenges such as high costs, regulatory hurdles, and limited reimbursement scenarios could temper market growth. Moreover, the risk of implant rejection and the technical difficulties associated with replicating natural cartilage's complex composition may deter rapid advancement. For business growth, the market should focus on innovations in nanotechnology to improve implants' mechanical properties and tissue integration. Further research into regenerative medicine, like stem cell therapy combined with artificial implants, presents promising avenues. The market's nature is highly competitive, with key players investing heavily in R&D to differentiate their offerings through features like patient-specific designs and improved longevity. Collaborations between biotech firms and research institutions can enhance product pipelines and broaden market reach. To capitalize on current trends, businesses should emphasize patient education and forge strong partnerships with healthcare providers, ensuring their products align with evolving clinical needs and regulatory landscapes.

KEY MARKET STATISTICS
Base Year [2023] USD 118.22 million
Estimated Year [2024] USD 135.79 million
Forecast Year [2030] USD 321.69 million
CAGR (%) 15.37%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Artificial Cartilage Implant Market

The Artificial Cartilage Implant Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
    • Rising awareness regarding artificial cartilage implants
    • Growing healthcare expenditure and advanced healthcare facilities
  • Market Restraints
    • High cost associated with the artificial cartilage and replacement surgeries
  • Market Opportunities
    • Technological advancements in implant materials and surgical techniques
    • Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
  • Market Challenges
    • Complications factors associated with artificial cartilage implants

Porter's Five Forces: A Strategic Tool for Navigating the Artificial Cartilage Implant Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Artificial Cartilage Implant Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Artificial Cartilage Implant Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Artificial Cartilage Implant Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Artificial Cartilage Implant Market

A detailed market share analysis in the Artificial Cartilage Implant Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Artificial Cartilage Implant Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Artificial Cartilage Implant Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Artificial Cartilage Implant Market

A strategic analysis of the Artificial Cartilage Implant Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Artificial Cartilage Implant Market, highlighting leading vendors and their innovative profiles. These include Anika Therapeutics, Inc., BioPoly, LLC, CartiHeal, Inc. by Smith & Nephew PLC, CytoSeek Limited, Medtronic PLC, Narang Medical Limited, NUsurface, Orthox Ltd., Sartorius CellGenix GmbH, Sparta Biomedical Inc., Stryker Corporation, Uteshiya Medicare, and Zimmer Biomet Holdings, Inc..

Market Segmentation & Coverage

This research report categorizes the Artificial Cartilage Implant Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Type, market is studied across Lower Extremity Joints, Upper Extremity Joints, and Vertebral Joints.
  • Based on End-User, market is studied across Ambulatory Surgery Centers, Clinics, and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing prevalence of osteoarthritis of knee joint and carpometacarpal
      • 5.1.1.2. Rising awareness regarding artificial cartilage implants
      • 5.1.1.3. Growing healthcare expenditure and advanced healthcare facilities
    • 5.1.2. Restraints
      • 5.1.2.1. High cost associated with the artificial cartilage and replacement surgeries
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancements in implant materials and surgical techniques
      • 5.1.3.2. Development of smart and 3D printing technologies for artificial cartilage implants manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Complications factors associated with artificial cartilage implants
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Increasing demand for lower extremity joints artificial cartilage implant owing to the high prevalence of osteoarthritis
    • 5.2.2. End-User: Rising demand for artificial cartilage implants in hospitals for extensive patient care facilities
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Artificial Cartilage Implant Market, by Type

  • 6.1. Introduction
  • 6.2. Lower Extremity Joints
  • 6.3. Upper Extremity Joints
  • 6.4. Vertebral Joints

7. Artificial Cartilage Implant Market, by End-User

  • 7.1. Introduction
  • 7.2. Ambulatory Surgery Centers
  • 7.3. Clinics
  • 7.4. Hospitals

8. Americas Artificial Cartilage Implant Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Artificial Cartilage Implant Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Artificial Cartilage Implant Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
    • 11.3.1. Swiss university launches artificial knee trial backed by USD 13 million
    • 11.3.2. Sparta strengthens patent protection for Ormi implant
    • 11.3.3. CartiHeal Announces First Commercial Implantation of Agili-C in the US
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Anika Therapeutics, Inc.
  • 2. BioPoly, LLC
  • 3. CartiHeal, Inc. by Smith & Nephew PLC
  • 4. CytoSeek Limited
  • 5. Medtronic PLC
  • 6. Narang Medical Limited
  • 7. NUsurface
  • 8. Orthox Ltd.
  • 9. Sartorius CellGenix GmbH
  • 10. Sparta Biomedical Inc.
  • 11. Stryker Corporation
  • 12. Uteshiya Medicare
  • 13. Zimmer Biomet Holdings, Inc.

LIST OF FIGURES

  • FIGURE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET RESEARCH PROCESS
  • FIGURE 2. ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ARTIFICIAL CARTILAGE IMPLANT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ARTIFICIAL CARTILAGE IMPLANT MARKET DYNAMICS
  • TABLE 7. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY LOWER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY UPPER EXTREMITY JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY VERTEBRAL JOINTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY AMBULATORY SURGERY CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM ARTIFICIAL CARTILAGE IMPLANT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ARTIFICIAL CARTILAGE IMPLANT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. ARTIFICIAL CARTILAGE IMPLANT MARKET, FPNV POSITIONING MATRIX, 2023